Clinical Trials Directory

Trials / Completed

CompletedNCT00168363

Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
207 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This Study will evaluate the safety and efficacy of brimonidine in patients with glaucoma or ocular hypertension

Conditions

Interventions

TypeNameDescription
DRUGbrimonidine

Timeline

Start date
2005-01-01
Primary completion
2006-08-01
Completion
2006-08-01
First posted
2005-09-15
Last updated
2011-05-30

Source: ClinicalTrials.gov record NCT00168363. Inclusion in this directory is not an endorsement.